Ā | Introduction of treatment for NMFIs | Before | After | Sources/estimation/comments |
---|---|---|---|---|
A | Median village population | 768 | McLean [17] | |
B | Monthly malaria tests carried out | 15.0 | 34.9 | McLean [17] |
C | % testing positive for malaria | 9.2% | 6.0% | McLean [17] |
D | Monthly incidence NMFI (regional average) | 38.4 | Capeding [42] | |
E | Monthly incidence malaria | 3.9 | 2.4 | (Dā*āC)/(1āāāC) |
F | Total incidence febrile illness | 42.3 | 40.8 | Dā+āE |
G | Probability febrile patient attends CHW | 35% | 86% | B/F |
H | Treated malaria cases | 1.4 | 2.1 | Bā*āC |
I | Untreated malaria cases | 2.5 | 0.4 | EāāāF |
J | Untreated malaria cases averted | Ā | 2.2 | āI |
K | Mortality rate in untreated malaria | 1% | Lubell [36] | |
L | Monthly malaria mortality averted per village | Ā | 0.029 | Jā*āK |
M | Years of life lost per death | 45 | Assumption | |
N | DALYs averted | Ā | 0.97 | Lā*āM |
O | Cost per CRP test | $1 | CRP test costs are as low as $0.5; additional costs of transport, storage and training included here | |
P | Incremental cost per month | Ā | $ 35 | 0*B2 |
Ā | ICER (cost per DALY averted) | Ā | $ 36 | P/N |